SCHEMBL3661426

SCHEMBL3661426

CC1(O)C=c2c(=O)oc3c(O)c(O)cc4c(=O)oc(c2c34)C1(C)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
MAPT P10636 5/20 0.57
RECQL P46063 4/20 0.57
HPGD P15428 3/20 0.57
BLM P54132 3/20 0.57
APEX1 P27695 3/20 0.57
TDP1 Q9NUW8 3/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
POLB P06746 3/20 0.57
GAA P10253 3/20 0.57
CA12 O43570 2/20 0.57
CA1 P00915 2/20 0.57
CA7 P43166 2/20 0.57
CA9 Q16790 2/20 0.57
CA13 Q8N1Q1 2/20 0.57
PKLR P30613 2/20 0.57
GALNT2 Q10471 2/20 0.57
LMNA P02545 2/20 0.57
MAPK1 P28482 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ellagic Acid SCHEMBL28824363 0.76 KDM4E (0.92) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL1645767 0.76 KDM4E (1.00) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL30475160 0.76 KDM4E (1.00) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL20429 0.76 KDM4E (1.00) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL29439360 0.76 KDM4E (1.00) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL8686551 0.74 KDM4E (0.96) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL8686557 0.74 KDM4E (0.96) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL21590140 0.74 KDM4E (0.96) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL177722 0.74 KDM4E (0.96) KDM4EMAPTRECQLHPGDBLM
Ellagic Acid SCHEMBL9146254 0.74 KDM4E (0.96) KDM4EMAPTRECQLHPGDBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR KDM4E 1101/4885MAPT 2549/4885RECQL 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.